Physician profile
Robert M Jasmer
NPI 1891746574
$97,871.73
in general payments reported to CMS, 2019-2025
47 companies · $23K in 2025
The $23K reported for 2025 was more than what 95% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $4,676 · 2021: $9,285 · 2022: $10K · 2023: $21K · 2024: $9,073 · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $9,768 · Travel and Lodging: $4,566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,153.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,700.00 |
| Food and Beverage | $9,767.70 |
| Travel and Lodging | $4,566.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $42,544.49 | 2019-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35,815.59 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Astrazeneca Pharmaceuticals Lp | $8,550.93 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $2,683.36 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Mylan Specialty L.P. | $1,146.42 | 2019-2024 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $755.78 | 2020-2025 | |
| Becton, Dickinson and Company | $600.00 | 2021 | |
| Electromed, INC. | $408.42 | 2019-2025 | Smartvest |
| Genzyme Corporation | $407.63 | 2019-2025 | |
| United Therapeutics Corporation | $392.38 | 2020-2025 | Tyvaso, Tyvaso, Orenitram |
| Actelion Pharmaceuticals US, INC. | $366.52 | 2019-2025 | Opsumit, Uptravi |
| Vertex Pharmaceuticals Incorporated | $360.00 | 2019 | |
| Merck Sharp & Dohme LLC | $349.65 | 2019-2025 | Zerbaxa, Recarbrio, Capvaxive |
| Regeneron Healthcare Solutions, INC. | $315.87 | 2019-2025 | Dupixent |
| Inari Medical, INC. | $315.53 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $224.36 | 2019-2022 | |
| Pulmonx Corporation | $219.22 | 2019-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Janssen Pharmaceuticals, INC | $215.69 | 2020-2023 | Xarelto |
| Baxter Healthcare | $198.89 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Amgen INC. | $179.98 | 2024-2025 | Tezspire, Tavneos |
| E.R. Squibb & Sons, L.L.C. | $173.63 | 2020-2024 | Eliquis, Camzyos |
| Grifols USA, LLC | $170.00 | 2019-2024 | Prolastin-C Liquid |
| Verona Pharma, INC. | $116.94 | 2025 | Ohtuvayre |
| Pfizer INC. | $116.41 | 2022-2024 | |
| Gilead Sciences, INC. | $114.74 | 2019-2024 | Veklury |
| Medtronic Vascular, INC. | $112.64 | 2019 | |
| Novartis Pharmaceuticals Corporation | $111.54 | 2019-2024 | |
| Philips North America LLC | $102.74 | 2024-2025 | (8874) Incourage, Vest Therapy Und |
| Advanced Respiratory, INC | $97.87 | 2019 | |
| Intuitive Surgical, INC. | $95.79 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $79.71 | 2022-2025 | Cuvitru, Hyqvia |
| Sanofi Pasteur INC. | $55.13 | 2019-2025 | |
| Lilly USA, LLC | $52.62 | 2025 | Zepbound, Mounjaro |
| Viatris Specialty LLC | $51.78 | 2025 | Yupelri |
| Erbe USA INC | $47.00 | 2024-2025 | Cryo2 |
| Teva Pharmaceuticals USA, INC. | $43.00 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $42.36 | 2019 | |
| Fisher & Paykel Healthcare INC | $38.18 | 2023-2024 | Fisher & Paykel Healthcare |
| Stryker Corporation | $34.61 | 2025 | Flowtriever |
| Circassia INC. | $30.96 | 2019 | |
| Astellas Pharma US INC | $23.81 | 2019 | |
| Mayne Pharma Commercial LLC | $22.82 | 2020 | |
| Resmed Corp | $21.75 | 2019 | |
| Kaleo, INC. | $20.70 | 2021 | |
| Chiesi USA, INC. | $16.77 | 2019 | |
| Sunovion Pharmaceuticals INC. | $14.01 | 2020 | |
| Inogen, INC. | $13.51 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jasmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.